renal cell carcinoma

Open Access
The Prognostic Role of Baseline and Early Dynamics of Peripheral Blood Cell Ratios in Metastatic Renal Cell Carcinoma Patients Treated With Nivolumab
ONDREJ FIALA, MICHAELA TKADLECOVA, JINDRICH KOPECKY, PETR HOSEK, HANA STUDENTOVA, MICHAL VOCKA, MARTIN MATEJU, RADKA LOHYNSKA, DOMINIKA SIKOVA, PETR STRANSKY, RADEK KUCERA, ANEZKA ZEMANKOVA, MARTINA SPISAROVA, PETER PRIESTER, JAN KOURIL, TOMAS BUCHLER, LUCIE GRMELOVA, BOHUSLAV MELICHAR and ALEXANDR POPRACH

In Vivo March 2026, 40 (2) 1065-1079; DOI: https://doi.org/10.21873/invivo.14261
Open Access
Serum Zinc Levels and Skin-related Adverse Events During Systemic Therapy for Renal Cell Carcinoma
SHINPEI SAITO, TOMOKAZU SAZUKA, HIROAKI SATO, YURI WATANABE, FUMIYA YOKOCHI, KOHEI TOMA, YUSUKE ONODA, KOTARO NAGAOKA, SANGJON PAE, KODAI SATO, KEISUKE ANDO, YASUTAKA YAMADA, YUSUKE IMAMURA and SHINICHI SAKAMOTO

In Vivo January 2026, 40 (1) 333-340; DOI: https://doi.org/10.21873/invivo.14196
Open Access
Comparative Analysis of Immune-based Combination Therapy as First-line Treatment for Advanced Renal Cell Carcinoma
YUTA MUKAE, KOJIRO OHBA, HIROMI NAKANISHI, MASAHARU OKI, KEN KAWADA, TSUYOSHI MATSUDA, KENSUKE MITSUNARI, TOMOHIRO MATSUO, YASUSHI MOCHIZUKI and RYOICHI IMAMURA

In Vivo January 2026, 40 (1) 389-397; DOI: https://doi.org/10.21873/invivo.14203
Open Access
Comparison of the Use of Immune Checkpoint Inhibitor/Tyrosine Kinase Inhibitor and Tyrosine Kinase Inhibitor Alone for Patients With Low Risk Metastatic Renal Cell Carcinoma
MASAHARU OKI, KOJIRO OHBA, YUTA MUKAE, TSUYOSHI MATSUDA, HIROMI NAKANISHI, KENSUKE MITSUNARI, TOMOHIRO MATSUO, YASUSHI MOCHIZUKI and RYOICHI IMAMURA

In Vivo November 2025, 39 (6) 3445-3452; DOI: https://doi.org/10.21873/invivo.14142
Open Access
Accuracy of Contrast-enhanced CT in Diagnosing Small-sized cT3a Renal Cell Carcinoma and Analysis of Factors Predicting Downstaging to pT1
KENSUKE BEKKU, KASUMI YOSHINAGA, SHOTA INOUE, YOSUKE MITSUI, TOMOAKI YAMANOI, TATSUSHI KAWADA, YUSUKE TOMINAGA, TAKUYA SADAHIRA, SATOSHI KATAYAMA, TAKEHIRO IWATA, SHINGO NISHIMURA, KOHEI EDAMURA, TOMOKO KOBAYASHI and MOTOO ARAKI

In Vivo September 2025, 39 (5) 2787-2793; DOI: https://doi.org/10.21873/invivo.14077
Open Access
Impact of Polypharmacy on Perioperative Outcomes of Robot-assisted Laparoscopic Partial Nephrectomy for Small Renal Masses
YUKI NEMOTO, HIROKI ISHIHARA, KAZUTAKA NAKAMURA, KOICHI NISHIMURA, HIRONORI FUKUDA, KAZUHIKO YOSHIDA, JUNPEI IIZUKA, TSUNENORI KONDO and TOSHIO TAKAGI

In Vivo September 2025, 39 (5) 2801-2809; DOI: https://doi.org/10.21873/invivo.14079
Open Access
Exploring Predictors of Hypertension Development With Pazopanib and Examining Predictive Performance Over Time
MASAYUKI KUNITAKE, AYA GOTO, YOSHIRO SAKAI, KYOKO HIGUCHI, IKKO MUTO, KOSUKE UEDA, TETSUYA HAMADA, KOJI HIRAOKA and KENTA MUROTANI

In Vivo July 2024, 38 (4) 1882-1890; DOI: https://doi.org/10.21873/invivo.13643
Open Access
Robot-assisted Partial Nephrectomy With Selective Artery Clamping for Renal Cell Carcinoma in Horseshoe Kidney
YUKI KOBARI, KAZUHIKO YOSHIDA, TAKANORI ENDO, RYO MINODA, HIRONORI FUKUDA, SHINSUKE MIZOGUCHI, JUNPEI IIZUKA, HIDEKI ISHIDA and TOSHIO TAKAGI

In Vivo July 2024, 38 (4) 2085-2089; DOI: https://doi.org/10.21873/invivo.13668
Open Access
Development of a New Focal Mouse Model of Bone Metastasis in Renal Cell Carcinoma
KEITA OYA, HIROYUKI TSUCHIE, HIROYUKI NAGASAWA, MICHIO HONGO, YUJI KASUKAWA, DAISUKE KUDO, RYO SHOJI, FUMIHITO KASAMA, TAKASHI KAWARAGI, MANABU WATANABE, KENTA TOMINAGA and NAOHISA MIYAKOSHI

In Vivo May 2024, 38 (3) 1074-1078; DOI: https://doi.org/10.21873/invivo.13541
Open Access
HECTD2/TNFAIP1 Axis Regulating the p38/JNK Pathway to Promote an Inflammatory Response in Renal Cell Carcinoma Cells
DONG LV, YONGBO CHEN, LIANGYOU TANG, YUCHANG TIAN, DONG REN, NENGHONG JIAN and TAIMIN SHEN

In Vivo May 2024, 38 (3) 1094-1103; DOI: https://doi.org/10.21873/invivo.13543

Main menu

User menu

Search

renal cell carcinoma

Pages